Charcot‐Marie‐Tooth Neuropathy Type 2 And P0 Point Mutations: Two Novel Amino Acid Substitutions (ASP61GLY, TYR119CYS) and a Possible “Hotspot” on THR124MET
Jan Senderek(Friedrich Baur Stiftung), J. M. Schröder(Maastricht University), Gisela Stoltenburg‐Didinger(Charité - Universitätsmedizin Berlin), Vincent Timmerman(University of Antwerp), G. Marx(International Society of Nephrology), Ulrich Lehmann(Medizinische Hochschule Hannover), Benita Hermanns(Universitätsklinikum Aachen), Christian Kabus(Jüdisches Krankenhaus Berlin), Carina Bergmann(International Society of Nephrology)
Cited by 5
Related Papers
Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A
|Nature Genetics|2004|1.6k
Mutant small heat-shock protein 27 causes axonal Charcot-Marie-Tooth disease and distal hereditary motor neuropathy
|Nature Genetics|2004|583
Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy
|Nature Genetics|2006|376
Differential roles of NHERF1, NHERF2, and PDZK1 in regulating CFTR-mediated intestinal anion secretion in mice
|Journal of Clinical Investigation|2009|361
A de novo gain-of-function mutation in SCN11A causes loss of pain perception
|Nature Genetics|2013|304